Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Journal of Inherited Metabolic Disease|August 12, 2008
The truth of treating patients with phenylketonuria after childhood: the need for a new guidelineF J van Spronsen, P BurgardJIMD Reports|February 23, 2013
Outcomes of phenylketonuria with relevance to follow-upF J van Spronsen, A Bélanger-QuintanaJournal of Inherited Metabolic Disease|April 5, 2001
Phenylketonuria: tyrosine beyond the phenylalanine-restricted dietF J van Spronsen, P G Smit, R KochJournal of Inherited Metabolic Disease|February 5, 2009
PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied DisordersF J van Spronsen, K Kiaer Ahring, M GizewskaJournal of Inherited Metabolic Disease|February 5, 2009
Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?F J van Spronsen, Marieke Hoeksma, Dirk-Jan ReijngoudNederlands Tijdschrift Voor Geneeskunde|September 24, 1999
[A child with dark discoloration of urine]Y M Jeucken, G Visser, A S Jaarsma, et al.Molecular Genetics and Metabolism|February 4, 2010
Animal models of brain dysfunction in phenylketonuriaA E Martynyuk, F J van Spronsen, E A Van der ZeeArchives of Disease in Childhood|August 1, 1994
Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering CommitteeP H Verkerk, F J van Spronsen, G P Smit, et al.Molecular Genetics and Metabolism|October 25, 2011
Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across developmentF J van Spronsen, S C J Huijbregts, A M Bosch, et al.Pediatric Hematology and Oncology|December 10, 2008
Recurrent thrombo-embolism in a child with a congenital disorder of glycosylation (CDG) type Ib and treatment with mannoseR Y J Tamminga, D J Lefeber, W A Kamps, et al.Pageof 8